Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment.

× No keyword cloud information.

42 in total

1. Are African American patients at a higher risk for olanzapine-induced glucose intolerance?

Authors: J Ananth; S Gunatilake; S Aquino; V Bach; J Costa
Journal: Psychopharmacology (Berl) Date: 2001-09 Impact factor: 4.530

Review 2. The interface of psychiatric disorders and diabetes mellitus.

Authors: M K Popkin; E A Colon
Journal: Curr Psychiatry Rep Date: 2001-06 Impact factor: 5.285

3. A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics.

Authors: Benjamin U Nwosu; Bruce Meltzer; Louise Maranda; Carol Ciccarelli; Daniel Reynolds; Laura Curtis; Jean King; Jean A Frazier; Mary M Lee
Journal: J Pediatr Endocrinol Metab Date: 2011 Impact factor: 1.634

Review 4. Metabolic consequences of atypical antipsychotic drugs.

Authors: Harold E Lebovitz
Journal: Psychiatr Q Date: 2003

5. Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.

Authors: Mikhail Kalinichev; Claire Rourke; Alex J Daniels; Mary K Grizzle; Christy S Britt; Diane M Ignar; Declan N C Jones
Journal: Psychopharmacology (Berl) Date: 2005-10-19 Impact factor: 4.530

New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment.

1. Are African American patients at a higher risk for olanzapine-induced glucose intolerance?

Review 2. The interface of psychiatric disorders and diabetes mellitus.

3. A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics.

Review 4. Metabolic consequences of atypical antipsychotic drugs.

5. Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.

6. Weight gain and new onset diabetes associated with olanzapine and risperidone.

Review 7. Acute hyperglycemia associated with short-term use of atypical antipsychotic medications.

Review 8. Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.

Review 9. Atypical antipsychotics and diabetic ketoacidosis: a review.

Review 10. Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.